# Future Work

The current repository represents a methodological framework for evaluating and optimizing analytical strategies in rare disease genomics.

Several future developments could expand the scope of the project, strengthen the benchmarking framework, and improve workflow reproducibility and clinical applicability.

---

## Analytical Validation of Structural Variant and mtDNA Modules

The structural variant and mitochondrial DNA modules are currently included as conceptual workflow components and methodological proposals.

Future work could focus on:

* Benchmarking structural variant callers using publicly available validation datasets.
* Evaluating concordance and complementary detection capabilities across multiple SV callers.
* Assessing mtDNA deletion and heteroplasmy detection performance using synthetic or simulated datasets.
* Incorporating additional SV and mtDNA analysis tools for broader comparative evaluation.
* Integrating quality control metrics related to coverage, breakpoint support, and confidence estimation.

These developments would help transition the modules from conceptual workflow proposals to validated analytical components.

---

## Expanded Variant Prioritization Benchmarking

The current benchmarking study focuses primarily on ranking behavior using previously diagnosed clinical cases.

Future extensions could include:

* Evaluation using larger and more diverse patient cohorts.
* Assessment of prioritization performance across different disease categories.
* Analysis of ranking robustness under incomplete or imprecise phenotype annotation.
* Comparison of updated software versions and annotation resources.
* Exploration of ensemble prioritization strategies combining evidence from multiple tools.
* Integration of phenotype simulation frameworks for systematic benchmarking.

These improvements would provide a more comprehensive understanding of prioritization performance while maintaining patient confidentiality.

---

## Workflow Automation and Reproducibility

To improve scalability, maintainability, and reproducibility, future workflow versions could incorporate:

* Reproducible software environments using Conda.
* Workflow management systems such as Nextflow or Snakemake.
* Containerization using Docker or Singularity.
* Automated logging, monitoring, and error handling.
* Version-controlled management of reference genomes, annotations, and external resources.

These developments would facilitate workflow deployment across research and clinical-adjacent environments.

---

## Clinical Interpretation Support

Future enhancements could strengthen the connection between variant prioritization and downstream interpretation by incorporating:

* ACMG/AMP classification support frameworks.
* Phenotype refinement and HPO optimization tools.
* Gene-disease validity resources.
* Automated generation of report-ready summaries.

These additions could help bridge the gap between analytical prioritization and clinical interpretation workflows.

---

Overall, these future developments aim to improve analytical robustness, reproducibility, scalability, and clinical relevance while maintaining the modular design principles that underpin this repository.
